Meredith Buxton Discusses the I-SPY 2 Trial
Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.
Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.
The goal of I-SPY 2 is to test new agents, like immunotherapies, and ultimately get them to patients sooner. While it is currently only being used in the breast cancer domain, Buxton noted that hopefully other cancer types will also join in the trial.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
